Wird geladen...
Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem(®)): differences in characteristics and misuse
There are distinct differences in the accessibility, purity, dosing, and misuse associated with illicit gamma-hydroxybutyrate (GHB) compared to pharmaceutical sodium oxybate. Gamma-hydroxybutyrate sodium and sodium oxybate are the chemical and drug names, respectively, for the pharmaceutical product...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2009
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2713368/ https://ncbi.nlm.nih.gov/pubmed/19493637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2009.04.012 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|